Zusammenfassung
Die folgenden Ausführungen basieren auf den Empfehlungen der Nationalen Versorgungs- Leitlinie Asthma [1] und der Deutschen Atemwegsliga [2]. Diese wiederum stimmen inhaltlich mit dem Scottish Guideline Intercollegiate Network (SIGN)/British Thoracic Society (BTS): Guideline on the Management of Asthma (2004) [www.brit-thoracic. org.uk/sign] und der WHO/NIH Global Initiative for Asthma, GINA (2006) [www. ginasthma.com]) überein.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Nationale Versorgungs-Leitlinie Asthma. Deutsches ärzteblatt 2005, 102: B2307-2311.
Buhl R, Berdel D, Criee C-P et al.: Leitlinie zur Diagnostik und Therapie von Patienten mit Asthma. Pneumologie 2006, 60: 139–83.
Barnes PJ, Pedersen S: Efficacy and safety of inhaled corticosteroids in asthma. Am Rev Respir Dis 1993, 148:S1–S26.
Nelson HS, Chapman KR, Pyke SD et al.: Enhanced synergy between fluticasone propionate and salmeterol inhaled from a single inhaler versus separate inhalers. J Allergy Clin Immunol 2003, 112:29–36.
Pauwels RA, Löfdahl C-G, Postma DS et al. for the Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. Effect of inhaled formoterol and budesonide on exacerbations of asthma. N Engl J Med 1997, 337:1405–1411.
Shrewsbury S, Pyke S, Britton M: Meta-analysis of increased dose of inhaled steroid or addition of salmeterol in symptomatic asthma (MIASMA). Br Med J 2000, 320:1368–1373.
Bjermer L, Bisgaard H, Bousquet J et al.: Montelukast and fluticasone compared with salmeterol and fluticasone in protecting against asthma exacerbation in adults: one year, double blind, randomised, comparative trial. Br Med J 2003, 327:891–895.
Laviolette M, Malmstrom K, Lu S et al.: Montelukast added to inhaled beclomethasone in treatment of asthma. Montelukast/Beclomethasone Additivity Group. Am J Respir Crit Care Med 1999, 160:1862–1868.
Davies B, Brooks G, Devoy M: The efficacy and safety of salmeterol compared to theophylline: meta-analysis of nine controlled studies. Respir Med 1998, 92:256–263.
Evans D J, Taylor DA, Zetterström O et al.: A comparison of low-dose inhaled budesonide plus theophylline and high-dose inhaled budesonide for moderate asthma. N Engl J Med 1997, 337:1412–1418.
Buhl R: Anti-IgE antibodies for the treatment of asthma. Curr Opin Pulm Med 2005, 11:27–34.
Bateman ED, Boushey HA, Bousquet J et al.: Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma Control Study. Am J Respir Crit Care Med 2004, 170: 836–44.
O’Byrne PM, Bisgaard H, Godard PP et al.: Budesonide/formoterol combination therapy as both maintenance and reliever medication in asthma. Am J Respir Crit Care Med 2005, 171: 129–36.
Rabe KF, Atienza T, Magyar P et al.: Effect of budesonide in combination with formoterol for reliever therapy in asthma exacerbation: a randomised, double-blind study. Lancet 2006, 368: 744–53.
Scicchitano R, Aalbers R, Ukena D et al.: Efficacy and safety of budesonide/formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma. Curr Med Res Opin 2004, 20: 1403–18.
Dahl R, Chuchalin A, Gor D et al.: ECXCEL: A randomised trial comparing salmeterol/ fluticasone propionate and formoterol/budesonide combinations in adults with persistent asthma. Respir Med 2006, 100: 1152–62.
Vogelmeier C, D’Urzo A, Pauwels R et al.: Budesonide/formoterol maintenance and reliever therapy: an effective asthma treatment option? Eur Respir J 2005, 26: 819–28.
Arzneimittelkommission der deutschen Ärzteschaft (s. http://www.akdae.de). Empfehlungen zur Therapie des Asthma bronchiale, 2001.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer Medizin Verlag Heidelberg
About this chapter
Cite this chapter
Ukena, D. (2007). Medikamentöse Therapie des Asthma bronchiale bei Erwachsenen. In: Lingner, H., Schwartz, FW., Schultz, K. (eds) Volkskrankheit Asthma/COPD. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-70920-6_19
Download citation
DOI: https://doi.org/10.1007/978-3-540-70920-6_19
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-70919-0
Online ISBN: 978-3-540-70920-6
eBook Packages: Medicine (German Language)